Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,816 | -6,051 | -4,194 | -2,385 | -1,139 |
| Depreciation Amortization | 10 | 28 | 19 | 12 | 6 |
| Accounts receivable | -39 | -9 | N/A | N/A | N/A |
| Other Working Capital | -462 | -112 | -511 | -242 | 5 |
| Other Operating Activity | 607 | 2,506 | 1,819 | 831 | 301 |
| Operating Cash Flow | $-1,700 | $-3,639 | $-2,868 | $-1,784 | $-828 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -43 | -13 | N/A | N/A |
| Investing Cash Flow | $-11 | $-43 | $-13 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 138 | 180 | 180 | 180 | 180 |
| Debt Issued | N/A | 250 | 88 | 250 | 250 |
| Debt Repayment | -7 | -21 | -12 | -10 | -6 |
| Common Stock Issued | 2,318 | 3,573 | 3,573 | 1,928 | 27 |
| Other Financing Activity | -116 | -353 | -116 | -142 | -83 |
| Financing Cash Flow | $2,333 | $3,630 | $3,712 | $2,207 | $368 |
| Beginning Cash Position | 437 | 489 | 489 | 489 | 489 |
| End Cash Position | 1,059 | 437 | 1,321 | 912 | 29 |
| Net Cash Flow | $622 | $-52 | $832 | $423 | $-460 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,700 | -3,639 | -2,868 | -1,784 | -828 |
| Capital Expenditure | -11 | -43 | -13 | N/A | N/A |
| Free Cash Flow | -1,711 | -3,682 | -2,881 | -1,784 | -828 |